Skip to content
EmergingResearch compoundLimited evidence

Conessine

Plant-derived experimental compound that blocks the histamine H3 receptor and raised alertness in animals; not studied in humans.

NootropicStimulantStimulantHistaminenoo.affects.histamineDopamineAcetylcholineNorepinephrine

Pharmacology

ClassStimulant · Histamine
Primary targetHistamine H3 receptor antagonist / inverse agonist
Targets3 receptor targets
Half-lifeNot well characterized in humans; the compound is highly lipophilic and penetrates the brain well (a validated serum LC-MS/MS method exists)
OnsetNo standardized human data; in animal studies the wakefulness-promoting effect appears rapidly
EvidenceLimited evidence
Affected systemsnoo.affects.histamineDopamineAcetylcholineNorepinephrine

Contents

DETAILED OVERVIEW

What is Conessine?

Conessine is a plant-derived compound (a steroidal alkaloid) extracted from the bark and seeds of Holarrhena antidysenterica, a tropical shrub. In traditional medicine it has long been used against dysentery and amoebic infections. It is not approved as a medicine anywhere; the pure compound is sold as a research chemical and is not intended for human consumption.

In the brain it blocks the histamine H3 receptor, which acts as a brake on the release of several stimulating messengers (such as dopamine); releasing this brake increased alertness in animal studies. It has never been tested in humans as a cognitive enhancer, so there are only early, mostly laboratory and animal data. Because it is stimulating, it could in theory cause insomnia, restlessness and a rise in heart rate and blood pressure; the alkaloids of the plant can also irritate the gut. Its safety in pregnancy and breastfeeding has not been established.

Mechanism

Histamine H3 antagonist / inverse agonist

Origin

Holarrhena antidysenterica steroidal alkaloid

Evidence

Preclinical (no human nootropic data)

Receptor profile

  • Histamine H3 receptorStrong
  • Alpha-adrenergic receptorsModerate
  • Acetylcholine / dopamine / norepinephrine release (indirect)Moderate

Safety

Side effects, stop signs, contraindications

Side effects · 5

  • No human nootropic safety data: the compound has not been tested as a cognitive enhancer in humans; effects derive from preclinical and pharmacological studies
  • Insomnia or disrupted sleep with late dosing, since it is stimulating and wakefulness-promoting
  • Possible rise in blood pressure and heart rate from the alpha-adrenergic and monoamine-releasing activity
  • Restlessness, anxiety or tremor from the enhanced histaminergic and catecholaminergic signaling
  • Unknown long-term safety; Holarrhena alkaloids carry gastrointestinal irritation potential at higher doses

Contraindications · 5

  • Pregnancy and breastfeeding: safety not established, avoid
  • Cardiovascular disease, arrhythmia or uncontrolled hypertension
  • Anxiety disorders, panic disorder: the stimulant effect may worsen them
  • Avoid combining with other stimulants or wakefulness agents due to additive effects
  • Not an approved medicine; experimental research chemical, not recommended without clinical supervision

Related Nootropics

Same therapeutic category

Studies

Related research and clinical findings

FAQ

FAQ

Conessine is a plant-derived alkaloid that boosts alertness and attention-related brain chemicals by blocking a specific brake in the brain, the histamine H3 receptor. Known traditionally from herbal use, in modern research it's studied mainly as a wakefulness-promoting, stimulating compound, largely at the animal-study stage.

Telegram

Have a question about Conessine?

Reach out to us on Telegram for a personalized stack. We'll be happy to help.

Personalized consultation

Want a detailed conversation tailored to your data?

Fill out the prep intake form (your goals, training and health data), and the advisor prepares from it to give genuinely personalized guidance.

Fill out the form

~5–7 min · prep questionnaire · confidential · GDPR-compliant

Structure & chemistry

TypeNootropic
FormulaC24H40N2
UpdatedOctober 13, 2026
MolekulaX Editorial Team·Source-verified · PubMed · FDA · EMA
Updated: October 13, 2026

The information here is strictly for educational and scientific purposes. It does not replace medical advice or clinical consultation, and it does not encourage illegal substance or pharmaceutical use. Data is sourced. When in doubt, consult your doctor.